Company news
Edx Medical Group Plc (AQUIS:EDX) news
Edx Medical Group Plc news releases on 6ix. Latest, Sep 2, 2024: Distribution agreement with Caris Life Sciences
Press releases — page 2
Distribution agreement with Caris Life Sciences
September 2, 2024
New 5-FU/Capecitabine Safety & Treatment Test
August 23, 2024
Investor Evening
July 12, 2024
Exclusive partnership for cancer assay
June 26, 2024
New development in cancer testing strategy
June 20, 2024
Admission to Apex segment of AQSE Growth Market
April 24, 2024
Appointment of Product Development Director
March 1, 2024
WRAP Retail Offer
February 28, 2024
Investment and Placing of New Shares
February 6, 2024
Director dealing - REPLACEMENT
January 5, 2024
Interim Report & Financial Statements
December 18, 2023
EDX Medical-Thermo Fisher Scientific collaboration
November 21, 2023
General Meeting results
October 25, 2023
Change of venue of General Meeting
October 18, 2023
Agreement to distribute cancer genomic tests
October 5, 2023
Posting of Notice of GM and Annual Report
October 2, 2023
Acquisition of Hutano Diagnostics Ltd
September 27, 2023
Posting of Notice of AGM
September 4, 2023
Commercial Director appointment
July 12, 2023
Strategic investment from Boru Ltd
June 30, 2023
EDX Medical Group PLC strengthens senior team
June 22, 2023
Appointment of Corporate Adviser and Broker
June 19, 2023
Strategic investment from Seerave Enterprises...
May 26, 2023
Director Dealing
March 13, 2023
Total Voting Rights Correction
March 1, 2023
Acquisition of Torax Biosciences
February 17, 2023
Interim Report for the six-months to 30 Septemb...
December 20, 2022
Collaboration Programme with Tianjin Bioscience
November 21, 2022
Holding(s) in Company
November 15, 2022
Admission to AQSE and First Day of Dealings
November 14, 2022